Any alpha,beta-unsaturated monocarboxylic acid based on the cinnamic acid skeleton and its substituted derivatives.
ChEBI ID: 23252
Member | Definition | Role |
---|---|---|
(E)-2-methoxycinnamic acid | A member of the class of cinnamic acids that is trans-cinnamic acid carrying a methoxy substituent at position 2 on the benzene ring. | (E)-2-methoxycinnamic acid |
3-[4-(1-imidazolylmethyl)phenyl]-2-propenoic acid | 3-[4-(1-imidazolylmethyl)phenyl]-2-propenoic acid | |
4-fluorocinnamic acid | 4-Fluorocinnamic acid | |
4-methoxycinnamic acid | (E)-3-(4-methoxyphenyl)prop-2-enoic acid | |
buniodyl | bunamiodyl | |
dimecrotic acid | dimecrotic acid | |
lusutrombopag | lusutrombopag | |
ozagrel | ozagrel | |
pd 150606 | An organoiodine compound that is acrylic acid in which the vinylic hydrogens at positions 2 and 3 are replaced by mercapto and 4-iodophenyl groups respectively (the Z geoisomer). | (Z)-3-(4-iodophenyl)-2-mercaptoacrylic acid |
zosteric acid | An aryl sulfate that is (2E)-3-phenylprop-2-enoic acid which is substituted by a sulfooxy group at position 4. It is produced by the seagrass Zostera marina and has very promising antifouling potential against several micro- and macrofouling organisms. | 4-(sulfooxy)-cinnamic acid |
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 204 (26.95) | 18.7374 |
1990's | 242 (31.97) | 18.2507 |
2000's | 135 (17.83) | 29.6817 |
2010's | 135 (17.83) | 24.3611 |
2020's | 41 (5.42) | 2.80 |
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 37 (4.56%) | 5.53% |
Reviews | 34 (4.19%) | 6.00% |
Case Studies | 21 (2.59%) | 4.05% |
Observational | 1 (0.12%) | 0.25% |
Other | 718 (88.53%) | 84.16% |